Trial Profile
Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate the Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) Administered by the Intramuscular Route in Adult Subjects Who Reside in a Flavivirus Endemic Area
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Apr 2023
Price :
$35
*
At a glance
- Drugs Zika virus vaccine-Sanofi (Primary)
- Indications Zika virus infection
- Focus Adverse reactions
- 26 Aug 2021 Status changed from active, no longer recruiting to completed.
- 16 Jan 2020 Status changed from recruiting to active, no longer recruiting.
- 10 Jan 2020 Planned End Date changed from 15 Jan 2020 to 2 Aug 2021.